Down Syndrome Clinical Trials in Houston, Texas
5 studies are recruiting for down syndrome in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
The overall objective of this randomized clinical trial is to test the effectiveness of a personalized approach to the surgical treatment of OSA in children with Down syndrome (DS).The estimated prevalence of obstructive sleep apnea (OSA) in children with DS ranges from 45-83%, compared to 1-6% in …
- Stage
- Not phased
- Ages
- 2 to 17
- Site
- Texas Children's Hospital, Houston, Texas
- Locations
- 7 in total
- Run by
- Oregon Health and Science University
-
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with relapsed B-ALL are included in this study. Blinatumoma…
- Stage
- Phase 2
- Ages
- 1 to 30
- Site
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
- Locations
- 227 in total
- Run by
- National Cancer Institute (NCI)
-
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
This study attempts to learn more about the health of persons with Down syndrome after treatment for acute leukemia. Children with Down syndrome are at increased risk for side effects during treatment for acute leukemia, but it is unclear of their risk for long-term effects of cancer treatment. By …
- Stage
- Not phased
- Ages
- 6 to 39
- Site
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
- Locations
- 73 in total
- Run by
- Children's Oncology Group
-
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK…
- Stage
- Not phased
- Ages
- 0 to 20
- Site
- Baylor College of Medicine, Houston, Texas
- Locations
- 52 in total
- Run by
- Duke University
-
Collaboration for Down Syndrome Progress (CDP)
The Collaboration for Down Syndrome Progress (CDP) is a long-term study that follows people with Down syndrome of all ages. The goal is to better understand their health, development, and everyday experiences over time. Participants and their caregivers will answer questions, share medical informat…
- Stage
- Not phased
- Ages
- Any age
- Site
- Texas Children's Hosptial/Baylor College of Medicine, Houston, Texas
- Locations
- 16 in total
- Run by
- RTI International
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.